Saturday 17 October 2026
Export PACS’s income statement to Excel — free account
PACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024. In the quarter to June 2026, revenue grew 9.07%, EPS grew 45.5%, free cash flow grew 220.5% and total debt fell 4.30%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
46.91
0.84
−1.76%
Follow PACS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 4 | — | — | — |
P/E ratio |
31.47 | 32.20 | 26.89 | 26.89 | 26.89 |
Altman Z-Score |
2.00 | 1.13 | — | — | — |
P/S ratio |
1.13 | 0.47 | 0.89 | 0.89 | 0.89 |
P/FCF ratio |
20.01 | 6.36 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
0.85 | 0.35 | 1.01 | 0.81 | — |
Beneish M-Score |
(2.74) | (2.39) | (1.95) | — | — |
P/Operating CF |
(1,768.67) | 29.77 | 50.39 | 50.39 | 50.39 |
P/B ratio |
6.30 | 2.69 | 22.16 | 22.16 | 22.16 |
Price to Tangible BV |
6.78 | 2.96 | 43.35 | 43.35 | 43.35 |
EV/Sales |
1.16 | 0.50 | 1.10 | 1.10 | 1.10 |
EV/EBITDA |
16.69 | 12.16 | 14.78 | 14.78 | 14.78 |
EV/Operating CF |
15.21 | 5.53 | 84.90 | 84.90 | 84.90 |
EV/FCF |
20.52 | 6.72 | (546.96) | (546.96) | (546.96) |
Quick Ratio |
0.90 | 0.89 | 1.47 | 0.99 | — |
Current Ratio |
1.07 | 0.96 | 1.58 | 1.06 | — |
Net Debt/EBITDA |
0.41 | 0.65 | 2.75 | 1.75 | 0.00 |
Debt/Assets |
6.25% | 5.07% | 20.85% | 20.30% | 0.00% |
Debt/Equity |
0.37 | 0.37 | 7.20 | 7.28 | 0.00 |
Asset Turnover |
0.98 | 0.93 | 1.04 | 1.97 | 0.00 |
Operating CF/Net income |
2.11 | 6.59 | 0.56 | 0.62 | 1.20 |
Capex/Depreciation |
(1.78) | (1.48) | (1.42) | (0.97) | (15.40) |
Interest Coverage |
10.92 | 2.78 | 4.16 | 8.98 | 15.79 |
| 22.96% | 13.64% | 132.50% | 0.00% | 0.00% | |
| 3.54% | 1.27% | 3.78% | 12.23% | 0.00% | |
ROIC |
17.52% | 9.34% | 17.07% | 28.10% | 0.00% |
Return on Tangible Assets |
15.09% | 5.87% | 13.39% | 32.87% | 0.00% |
Average Days of Receivables |
48.45 | 63.95 | 70.39 | 63.31 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
7.85% | 8.41% | 6.87% | 6.15% | 8.30% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.02 | 0.03 | 0.00 |
Share Based Compensation of Revenue |
1.02% | 2.83% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.59) | (1.87) | (0.98) | (0.98) | (0.98) |
Graham Number |
12.94 | 6.69 | 3.95 | 0.00 | 0.00 |
Earnings Yield |
3.18% | 3.11% | 3.72% | 3.72% | 3.72% |
Free Cash Flow Yield |
5.00% | 15.73% | (0.23%) | (0.23%) | (0.23%) |
Revenue per Share |
33.86 | 27.89 | 24.17 | 18.82 | 9.06 |
Operating CF per Share |
2.59 | 2.50 | 0.49 | 0.72 | 0.45 |
Capex per Share |
(0.67) | (0.44) | (0.35) | (0.18) | (0.96) |
Free Cash Flow per Share |
1.92 | 2.06 | 0.15 | 0.54 | (0.52) |
Cash per Share |
1.26 | 1.08 | 0.57 | 0.45 | 0.00 |
Shareholders Equity per Share |
6.10 | 4.88 | 0.79 | 0.53 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.10 | 4.88 | 0.79 | 0.53 | 0.00 |
Free Cash Flow |
299.57 | 302.38 | 18.67 | 69.76 | (66.48) |
Working Capital |
68.31 | (40.17) | 265.22 | 27.30 | — |
Capital Expenditures |
(104.65) | (64.96) | (45.03) | (22.85) | (124.09) |
Net Current Asset Value |
(3,561.85) | (3,588.96) | (2,688.87) | (1,882.08) | 0.00 |
EV/EBIT |
19.86 | 16.50 | 17.14 | 17.14 | 17.14 |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.01 | 0.11 |
Price to Operating Income |
19.37 | 15.62 | 13.85 | 13.85 | 13.85 |
| Other line items | |||||
Depreciation/Fixed assets |
0.05 | 0.04 | 0.05 | 0.05 | 0.00 |
Cash ROIC |
19.99% | 26.54% | 2.06% | 11.13% | 0.00% |
Accounts Receivable Turnover |
7.46 | 6.21 | 6.10 | 0.00 | 0.00 |
Accounts Payable Turnover |
24.55 | 22.67 | 21.19 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
15.56 | 17.84 | 19.31 | 19.97 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
709.31 | 658.29 | 510.10 | — | — |
Average Payables |
183.65 | 158.00 | 125.76 | — | — |
Average Assets |
5,413.47 | 4,377.82 | 2,987.32 | 1,230.95 | — |
Average Common Equity |
834.07 | 408.71 | 85.19 | — | — |
Columns are period end dates